Clinical evaluation of 413 Thalassemic patients

Rabbani A,; Azar Keiwan A,; Farhadi Langeroudi M,; Korosdari Gh.H,

Volume 58, Issue 3 (7 2000) Tehran Univ Med J 2000, 58(3): 35-41 | Back to browse issues page

Mendeley

Zotero

RefWorks

Rabbani A, Azar Keiwan A, Farhadi Langeroudi M, Korosdari Gh.H. Clinical evaluation of 413 Thalassemic patients. Tehran Univ Med J 2000; 58 (3) :35-41
URL: http://tumj.tums.ac.ir/article-1-1385-en.html

Clinical evaluation of 413 Thalassemic patients

Rabbani A

, Azar Keiwan A

, Farhadi Langeroudi M

, Korosdari Gh.H

Abstract: (10080 Views)

Thalassemia is the most prevalent genetic disorder in Iran and around the world and these patients need regular careful care. The present study reports results of routine examination of patients visited Thalassemia clinic of Tehran. Data about clinical and laboratory examinations of 413 Thalassemic were extracted and analyzed. The prevalence of heart complications, diabetes, growth retardation, delayed puberty and primary and secondary amenorrhea was 9%, 8%, 21.3%, 3.1% and 6.3%, respectively. 44% didn't have secondary sex characteristics. Splenectomy had been done for 67.2% of cases. HBsAg, HBsAb and HBcAb were positive in 1.9%, 57.4% and 43%, respectively. We concluded that blood transfusion standards in this clinic was acceptable, whereas because of poor knowledge, iron chelating is unfavorable.

Keywords: Iron chelation

Full-Text [PDF 1250 kb] (1642 Downloads)